Evolus (EOLS) Stock Chart & Stock Price History $9.20 -0.07 (-0.70%) Closing price 03:59 PM EasternExtended Trading$9.21 +0.01 (+0.05%) As of 04:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Evolus Stock Price Performance The Evolus (EOLS) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 23.42%, with a year-to-date return of -16.62%. In the past month, the stock has decreased 7.58%, reflecting recent market activity. As of the latest close, Evolus traded at $9.27 with a market cap of $597.73 million and volume of 1.31 million shares. Five years ago, the stock traded at $3.37, representing a 173.15% increase over that period. At the time, it had a market cap of $116.02 million and a volume of 695,100 shares. Receive EOLS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Evolus and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-2.90%1 Month Performance-7.58%3 Month Performance-8.95%Year-To-Date Performance-16.62%1 Year Performance-23.42%5 Year Performance+173.15% EOLS Stock Chart for Wednesday, July, 16, 2025 EOLS Chart by TradingView Evolus Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/15/2025$9.51$9.27-2.52%$9.60$9.191.31 million shs$597.73 million07/14/2025$9.48$9.51+0.32%$9.64$9.43690,879 shs$613.21 million07/11/2025$9.73$9.48-2.57%$9.75$9.45852,343 shs$611.27 million07/10/2025$9.66$9.73+0.72%$9.84$9.50555,550 shs$627.39 million07/09/2025$9.26$9.66+4.32%$9.95$9.30898,693 shs$622.84 million07/08/2025$9.14$9.26+1.31%$9.41$9.12610,833 shs$597.09 million07/07/2025$9.27$9.14-1.40%$9.37$9.10922,763 shs$589.35 million07/04/2025$9.27$9.27$9.28$9.11424,231 shs$597.73 million07/03/2025$9.21$9.27+0.65%$9.28$9.11424,231 shs$597.73 million07/02/2025$9.20$9.21+0.11%$9.39$9.151.07 million shs$593.86 million Get the Latest News and Ratings for EOLS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Evolus and its competitors with MarketBeat's FREE daily newsletter. 07/01/2025$9.21$9.20-0.11%$9.63$9.001.12 million shs$593.22 million06/30/2025$9.14$9.21+0.77%$9.38$9.07796,103 shs$593.82 million06/27/2025$9.31$9.14-1.83%$9.42$9.05779,621 shs$589.35 million06/26/2025$9.10$9.31+2.31%$9.32$9.00711,427 shs$600.31 million06/25/2025$9.62$9.10-5.41%$9.57$9.09684,915 shs$586.77 million06/24/2025$9.38$9.62+2.56%$9.68$9.28970,719 shs$620.30 million06/23/2025$9.28$9.38+1.08%$9.47$9.13900,491 shs$604.82 million06/20/2025$9.30$9.28-0.22%$9.43$9.22712,649 shs$598.37 million06/19/2025$9.30$9.30$9.48$9.19655,952 shs$599.66 million06/18/2025$9.25$9.30+0.54%$9.48$9.19655,952 shs$599.66 million06/17/2025$9.96$9.25-7.13%$9.88$9.082.18 million shs$596.40 million06/16/2025$9.93$9.96+0.30%$10.06$9.80762,050 shs$642.18 million Related Companies Arrowhead Pharmaceuticals Stock Chart Apellis Pharmaceuticals Stock Chart NewAmsterdam Pharma Stock Chart Twist Bioscience Stock Chart Denali Therapeutics Stock Chart Kiniksa Pharmaceuticals International Stock Chart Agios Pharmaceuticals Stock Chart Recursion Pharmaceuticals Stock Chart CG Oncology Stock Chart Vericel Stock Chart Receive EOLS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Evolus and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:EOLS) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredRevolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial UnderwayTiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare!Interactive Offers | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBank of America Says Gold Could Hit $4,000. Here How to Get Paid“I’ve always hated gold. It doesn’t pay dividends… it just sits there.” That’s what one income strategist b...Investors Alley | SponsoredI warned you about Nvidia… now look what’s happeningNvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before t...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evolus, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evolus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.